The cheapest weight loss injection depends on insurance, coupons, pharmacy pricing, and whether a licensed clinician prescribes a brand-name or compounded GLP-1. Some insured patients pay as little as $0–$25 for FDA-approved brands, while cash-pay options often cost more. At Chia, clinician-reviewed compounded semaglutide injections currently start at $249/month and compounded tirzepatide injections at $299/month when appropriate; compounded drugs are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is the cheapest weight loss injection?
The cheapest option is not the same for everyone. Weight loss injections can cost very little with strong insurance coverage, or much more when paid fully out of pocket.
For brand-name GLP-1 medications, the lowest advertised prices usually depend on insurance coverage, prior authorization, and a manufacturer savings card. FDA-approved weight-loss brands include Wegovy (semaglutide, a GLP-1 receptor agonist), Zepbound (tirzepatide, a GIP/GLP-1 receptor agonist), and Saxenda (liraglutide, a GLP-1 receptor agonist) 1 2 5.
Quick facts: realistic monthly price ranges
- With insurance and a valid savings card, some patients pay about $0–$25/month for Wegovy or Zepbound, depending on plan rules and coupon terms 8 9.
- Without insurance, brand-name GLP-1 list prices are often around $1,000 or more per month before discounts, cash-pay programs, or pharmacy price changes 8 9.
- Cash-pay compounded GLP-1 programs may cost less than brand-name list prices, but quality depends on a licensed prescriber and a state-licensed 503A compounding pharmacy 10.
- At Chia, compounded semaglutide injection plans currently start at $249/month, and compounded tirzepatide injection plans currently start at $299/month.
Why there is no single cheapest option for everyone
A low price can depend on diagnosis, BMI, employer benefits, state rules, pharmacy stock, and whether the drug is covered for obesity, overweight with a weight-related condition, or type 2 diabetes. Wegovy and Zepbound labels include chronic weight management indications, while Ozempic and Mounjaro are FDA-approved for type 2 diabetes 1 2 3 4.
When a low advertised price depends on insurance, coupons, or eligibility
Savings cards usually have rules. They may require commercial insurance, exclude government insurance, set a maximum monthly savings amount, and change over time 8 9. That is why a $25 headline price may be real for one person and unavailable for another.
How much do weight loss injections cost with insurance?
With insurance, GLP-1 costs can range from a small copay to full cash price. The biggest variable is whether your plan covers obesity medications and approves the specific drug.
Why some people pay $0–$25 for Wegovy or Zepbound
Some patients with commercial insurance qualify for manufacturer savings programs that can lower their out-of-pocket cost. Novo Nordisk and Lilly describe savings card programs for Wegovy and Zepbound, but the exact amount depends on coverage status, eligibility rules, and program limits 8 9.
Prior authorization, BMI criteria, and plan exclusions
Many plans require prior authorization before covering weight-loss injections. Clinicians often need to document BMI, weight-related conditions such as high blood pressure, high cholesterol, sleep apnea, prediabetes, PCOS, or MASH, and past lifestyle efforts. FDA labels for Wegovy and Zepbound include use in adults with obesity or overweight with at least one weight-related condition 1 2.
Why Ozempic or Mounjaro may be covered for diabetes but not weight loss
Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved to improve glycemic control in adults with type 2 diabetes, with additional cardiovascular-related labeling for Ozempic in certain patients 3 4. If someone uses these medications for weight loss without type 2 diabetes, that use may be off-label, and insurance coverage may be denied.
How much do weight loss injections cost without insurance?
Without insurance, cash-pay pricing is often the main issue. Brand-name injections can be much more expensive than compounded programs, but cash prices can change by pharmacy, location, dose form, and availability.
Brand-name GLP-1 list prices versus cash-pay programs
Brand-name Wegovy, Zepbound, Ozempic, Mounjaro, and Saxenda often have high list prices before discounts. Manufacturer cash-pay options and savings cards may lower costs for some patients, but terms are specific and can change 8 9.
Semaglutide, tirzepatide, and liraglutide cost differences
Semaglutide, tirzepatide, and liraglutide are different active ingredients. Semaglutide is a GLP-1 receptor agonist, tirzepatide acts at GIP and GLP-1 receptors, and liraglutide is an older daily GLP-1 injection 1 2 5. Generic liraglutide may lower some costs over time, but pharmacy pricing and coverage still vary.
What to ask before choosing a cash-pay program
- Is the listed price medication-only, or does it include the clinician visit, follow-up, supplies, and shipping?
- Does a licensed US clinician review your health history before prescribing?
- Which pharmacy fills the prescription, and is it state-licensed?
- Are labs, refills, dose changes, cancellation terms, and support included?
- Does the program clearly explain side effects, contraindications, and what to do if symptoms occur?
Are compounded GLP-1 injections a lower-cost option?
They can be. Compounded GLP-1 injections may cost less than brand-name list prices, but they should only be used with a prescription, clinician oversight, and a licensed 503A compounding pharmacy.
Compounded semaglutide via a 503A pharmacy and compounded tirzepatide via a 503A pharmacy are custom-prepared medications for an individual patient after a clinician determines they are appropriate. The FDA explains that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing 10.
How 503A compounding pharmacies differ from FDA-approved manufacturers
FDA-approved manufacturers make approved products under FDA-reviewed applications. A 503A compounding pharmacy prepares patient-specific prescriptions under pharmacy compounding rules and state pharmacy oversight, but the compounded drug itself does not go through FDA approval 10.
Safety questions to ask any telehealth provider or pharmacy
- Will a licensed clinician review my BMI, medical history, current medicines, and contraindications before prescribing?
- Is the pharmacy state-licensed, and is the medication compounded in the US?
- How do I reach the care team if nausea, vomiting, dehydration, abdominal pain, or low blood sugar symptoms occur?
- What is the follow-up plan for dose changes, side effects, missed doses, and refills?
- Does the program avoid no-prescription sales and research-chemical products?
3-min quiz
Compare clinician-reviewed GLP-1 options
Chia offers compounded semaglutide injection plans from $249/month and compounded tirzepatide injection plans from $299/month when clinically appropriate. A licensed provider reviews your health history before prescribing, and a prescription is never guaranteed. Compounded drugs are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality.
Cheap semaglutide versus cheap tirzepatide: how do they compare?
Both can be effective for weight management when clinically appropriate, but semaglutide and tirzepatide differ in receptor targets, evidence, side effects, coverage, and price. The lowest price is not always the best fit.
In the STEP 1 trial, adults with overweight or obesity without diabetes received semaglutide 2.4 mg once weekly plus lifestyle intervention; average weight change at 68 weeks was greater with semaglutide than placebo, but gastrointestinal side effects were common and individual results varied 6. In SURMOUNT-1, adults with obesity or overweight without diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly; average weight change at 72 weeks was greater than placebo, with gastrointestinal side effects also common and individual results varied 7. These trials studied the active ingredients in specific trial products; outcomes are not established for compounded formulations.
| Option | Active ingredient | FDA-approved use | Typical access issue | Cost notes |
|---|---|---|---|---|
| Wegovy | Semaglutide | Chronic weight management in eligible adults and certain pediatric patients; cardiovascular risk reduction in certain adults with established cardiovascular disease and obesity or overweight | Prior authorization and plan exclusions | May be low with insurance and savings card; high list price without coverage 1 8 |
| Ozempic | Semaglutide | Type 2 diabetes; certain cardiovascular and kidney-related indications in diabetes labeling | Coverage often tied to type 2 diabetes | Weight-loss use may be off-label; coupon rules vary 3 |
| Zepbound | Tirzepatide | Chronic weight management in eligible adults; obstructive sleep apnea in certain adults with obesity | Prior authorization and plan exclusions | May be low with insurance and savings card; cash-pay options may apply for some patients 2 9 |
| Mounjaro | Tirzepatide | Type 2 diabetes | Coverage often tied to type 2 diabetes | Weight-loss use may be off-label; coverage varies 4 |
| Saxenda | Liraglutide | Chronic weight management in eligible adults and certain pediatric patients | Daily injection and coverage limits | May differ from newer weekly options; generic liraglutide pricing varies 5 |
| Compounded semaglutide | Semaglutide | Not FDA-approved as a compounded drug | Requires clinician evaluation and licensed 503A pharmacy | Chia injection plans currently start at $249/month; not equivalent to Wegovy or Ozempic 10 |
| Compounded tirzepatide | Tirzepatide | Not FDA-approved as a compounded drug | Requires clinician evaluation and licensed 503A pharmacy | Chia injection plans currently start at $299/month; not equivalent to Zepbound or Mounjaro 10 |
Effectiveness, side effects, and access considerations
GLP-1 and GIP/GLP-1 medications can reduce appetite and improve satiety signaling, but they can also cause nausea, vomiting, diarrhea, constipation, abdominal pain, and dehydration risk. FDA labels also warn about specific risks and contraindications, including personal or family history of medullary thyroid carcinoma or MEN2 for semaglutide and tirzepatide products, and clinicians review pancreatitis history, gallbladder disease, kidney issues, pregnancy, and medication interactions before prescribing 1 2.
Why the lowest price is not always the best fit
A lower monthly price is helpful only if the care is safe and complete. Look at the prescriber, pharmacy, follow-up access, side-effect support, labs when needed, and total monthly cost.
Weight loss injections at Chia: compounded semaglutide and tirzepatide options
At Chia, compounded GLP-1 care starts with a 100% online evaluation. A licensed US provider reviews your health history and prescribes only when clinically appropriate.
We offer semaglutide injection plans that currently start at $249/month and tirzepatide injection or tablet plans that currently start at $299/month for injections and $249/month for tablets. Microdosing plans are available for semaglutide and tirzepatide when our providers determine that approach fits the patient’s goals and safety profile. These compounded formulations are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality.
| Chia option | Forms listed in Chia catalog | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | Provider-guided dosing; microdosing plans available when clinically appropriate |
| Tirzepatide | Tablets and injection | Tablets from $249/month; injection from $299/month | Provider-guided dosing; microdosing plans available when clinically appropriate |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/month | For patients whose provider recommends a combined plan; see Weight + Energy |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/month | For patients whose provider recommends a combined plan; see Weight + Muscle |
If prescribed, medication is compounded in the US by state-licensed 503A pharmacies and shipped to your door. Patients can message their care team through the portal between visits.
How can you lower the cost of weight loss injections safely?
The safest way to lower cost is to compare the full path: coverage, coupon rules, clinician review, pharmacy quality, and follow-up. No-prescription GLP-1 sellers are not a safe shortcut.
- 1Check your insurance formulary for Wegovy, Zepbound, Saxenda, Ozempic, and Mounjaro, and ask whether prior authorization is required.
- 2Use manufacturer savings cards only if you meet the eligibility rules, because restrictions and maximum savings can change 8 9.
- 3Compare the total cash price, not just the medication price. Include visits, labs, supplies, shipping, refills, and cancellation terms.
- 4Ask whether the program uses licensed clinicians and state-licensed 503A pharmacies for compounded medication 10.
- 5Avoid products sold as research chemicals, no-prescription injections, or peptides for human use without medical evaluation.
Who may qualify for prescription weight loss injections?
Eligibility depends on the medication, the label or prescribing rationale, and the clinician’s judgment. BMI and health history are usually central to the review.
FDA labels for Wegovy, Zepbound, and Saxenda include adults with obesity or adults with overweight and at least one weight-related condition, such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease depending on the product label 1 2 5. Clinicians also review pregnancy, breastfeeding, pancreatitis history, gallbladder disease, kidney disease, diabetes medications, gastrointestinal disease, and other factors before prescribing.
Other medications for weight management, including orlistat, Contrave, and phentermine, may be considered in some care settings, but they are not injections and have different risks, contraindications, and costs. The Obesity Medicine Association describes several FDA-approved anti-obesity medication classes and notes that treatment choice should be individualized 11.
There is no single cheapest provider for everyone. Some insured patients pay very little for brand-name GLP-1s with coverage and savings cards. Cash-pay patients may find lower prices through licensed compounded programs, but they should compare the clinician review, pharmacy, follow-up, and total monthly cost.
Ozempic savings offers usually depend on commercial insurance, coverage status, and program rules. Ozempic is FDA-approved for type 2 diabetes, not weight loss, so coverage is often tied to a diabetes diagnosis.
Some people pay about $25 for Wegovy when their insurance covers it and they qualify for the manufacturer savings card. If your plan excludes weight-loss medications or denies prior authorization, your cost may be much higher.
Without insurance, compounded semaglutide or compounded tirzepatide through a licensed clinician and 503A pharmacy may cost less than brand-name list prices. Chia’s compounded semaglutide injection plans currently start at $249/month, and compounded tirzepatide injection plans currently start at $299/month when appropriate.
Compounded GLP-1 injections should only be used with a licensed clinician and a state-licensed 503A pharmacy. Compounded drugs are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality, so pharmacy quality, prescribing oversight, and follow-up matter.
No. Compounded semaglutide uses the active ingredient name semaglutide, but it is a different, non-FDA-approved product from Wegovy or Ozempic. It should not be described as a generic or equivalent version of those brands.
No. Compounded tirzepatide uses the active ingredient name tirzepatide, but it is a different, non-FDA-approved product from Zepbound or Mounjaro. It should not be called a generic or equivalent version of those brands.
Yes, if a licensed clinician reviews your health history and prescribes when appropriate. At Chia, patients can start with the online eligibility quiz, and AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A prescription is never guaranteed.
3-min quiz
Start with a licensed-provider review
If you are comparing GLP-1 costs, Chia can help you understand whether compounded semaglutide or tirzepatide is clinically appropriate for you. The visit is online, prescriptions are reviewed by licensed US providers, and eligible prescriptions are filled by state-licensed 503A pharmacies and shipped to your door.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 3.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 4.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
- 5.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information. 2023.
- 6.Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- 7.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 8.Novo Nordisk. Wegovy savings and support information. 2026.
- 9.Eli Lilly and Company. Zepbound savings card and cash-pay information. 2026.
- 10.U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. 2024.
- 11.Obesity Medicine Association. Anti-obesity medications: weight loss medications. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



